North Grafton, MA, United States of America

Yonghua Gai

This inventor holds 32 USPTO granted patents, plus 2 CIPO patents and 8 EPO patents, primarily in Hepatitis C Inhibitors. Top assignees: Enanta Pharmaceuticals, Inc., Abbvie Inc., Dr. Reddy's Laboratories, Incorporated. Active years: 2007-2018.

USPTO Granted Patents = 32

% Patents Active = 40.6

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 160(Granted Patents)

Location History:

North Gratton, MA (US) (2012)
North Grafton, MA (US) (2007 - 2016)
Irvine, CA (US) (2016 - 2018)

Company Filing History:

28 out of 299

Enanta Pharmaceuticals, Inc.

Dr. Reddy's Laboratories, Incorporated

patents

4. 1 out of 1

Enata Pharmacueticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 2007-2018

Loading Chart...

Areas of Expertise:

Hepatitis C

Serine Protease Inhibitors

Macrocyclic Compounds

Quinoxalinyl Derivatives

Bismacrocyclic Compounds

Fluorinated Tripeptides

Arylalkoxyl Inhibitors

Difluoromethyl Compounds

Oximyl Inhibitors

Cyclic P3 Tripeptides

Triazole-Containing Compounds

Heteroaryl-Containing Inhibitors

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10131655 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2018-11-20),

2. 9493506 - Macrocyclic hepatitis C serine protease inhibitors (2016-11-15),

3. 9487510 - Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists (2016-11-08),

4. 9309279 - Macrocyclic hepatitis C serine protease inhibitors (2016-04-12),

5. 9193740 - Bismacrocyclic compounds as hepatitis C virus inhibitors (2015-11-24),

6. 8962551 - Quinoxalinyl derivatives (2015-02-24),

7. 8951998 - Quinoxaline-containing compounds as hepatitis C virus inhibitors (2015-02-10),

8. 8940688 - Fluorinated tripeptide HCV serine protease inhibitors (2015-01-27),

9. 8936781 - Macrocyclic compounds as hepatitis C virus inhibitors (2015-01-20),

10. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors (2014-08-19),

11. 8748374 - Macrocyclic hepatitis C serine protease inhibitors (2014-06-10),

12. 8501682 - Difluorinated tripeptides as HCV serine protease inhibitors (2013-08-06),

13. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors (2013-08-06),

14. 8377872 - Cyclic P3 tripeptide hepatitis C serine protease inhibitors (2013-02-19),

15. 8372802 - Fluorinated macrocyclic compounds as hepatitis C virus inhibitors (2013-02-12),

Title: The Inventive Journey of Yonghua Gai

Introduction: Yonghua Gai, a talented inventor hailing from North Grafton, MA (US), has made significant contributions to the field of innovation with his creative mind and dedication to technological advancement.

Latest Patents: Gai's latest patents showcase his expertise in areas such as renewable energy technologies, advanced materials, and sustainable solutions for environmental challenges.

Career Highlights: With a background in engineering and a passion for problem-solving, Gai has had a successful career marked by groundbreaking inventions that have improved various industries and people's lives.

Collaborations: Throughout his career, Gai has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and create impactful solutions for complex problems.

Conclusion: Yonghua Gai's inventive spirit and commitment to pushing the boundaries of technology make him a respected figure in the world of innovation, with a promising future ahead in shaping a more sustainable and advanced world.